Trump-Trimmed FDA Finally Releases A Batch Of PSGs – Back To Business As Usual?
New And Revised PSGs For Inhalers, Epinephrine, And User-Friendly Formulations
After half a year of silence, the US FDA has published 48 product-specific guidances for generic development. With critical staff laid off, will the health agency stick to its updated PSG publishing schedule?
